Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

MGRX stock hub

Mangoceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

MGRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

MGRX

In the news

Latest news · MGRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-141.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-74.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All MGRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001938046
Company name	Mangoceuticals, Inc.
Country	United States
Country code	US
Cusip	56270V106
Employees	3
Employees Change	1%
Employees Change Percent	50
Enterprise value	$5.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Health Information Services
IPO Date	2023-03-21
Isin	US56270V2051
Last refreshed	2026-05-10
Market cap	$7M
Market cap category	Nano-Cap
Price	$0.41
Price currency	USD
Rev Per Employee	152,007x
Sector	Healthcare
Sic	8090
Symbol	MGRX
Website	https://www.mangoceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-312.88%
EV/Sales	12.71x
FCF yield	-83.89%
P/B ratio	0.43x
P/S ratio	15.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	54.91%
Gross Profit	$250,386
Gross Profit Growth	-34.1%
Gross Profit Growth Q	-40.73%
Gross Profit Growth3 Y	272.35%
Net Income	$-21.8M
Net Income Growth Years	0%
Pretax Margin	-4,526.86%
Profit Per Employee	$-7.3M
ROA	-69.91
ROCE	-115.8
ROE	-141.7
ROIC	-74.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-76.8%
Cagr3y	-72.01%
EPS Growth Quarters	8
EPS Growth Years	2
Revenue Growth	-25.96x
Revenue Growth Q	-10.34x
Revenue Growth Years	0x
Revenue Growth3 Y	270.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.03
Assets	$16.1M
Cash	$1.5M
Current Assets	$1.5M
Current Liabilities	$890,568
Debt	$307,823
Debt Equity	$0.02
Equity	$15.2M
Interest Coverage	-170
Liabilities	$890,568
Long Term Assets	$14.5M
Long Term Liabilities	$0
Net Cash	$1.2M
Net Cash By Market Cap	$16.9
Net Debt Equity	$-0.08
Tangible Book Value	$967,965
Tangible Book Value Per Share	$0.06
WACC	16.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.74
Net Working Capital	$-521,649
Quick ratio	1.67
Working Capital	$656,866
Working Capital Turnover	$-1.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-408.93%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-76.78%
200-day SMA	1.19
3Y total return	-97.81%
50-day SMA	0.38
50-day SMA vs 200-day SMA	50under200
All Time High	65.55
All Time High Change	-99.37%
All Time High Date	2023-03-21
All Time Low	0.16
All Time Low Change	153.7%
All Time Low Date	2026-03-20
ATR	0.06
Beta	2.11
Beta1y	-2.18
Beta2y	-0.94
Ch YTD	-44.46
High	0.47
High52	2.75
High52 Date	2025-10-22
High52ch	-85.05%
Low	0.3
Low52	0.16
Low52 Date	2026-03-20
Low52ch	153.7%
Ma50ch	7.87%
Premarket Change Percent	0.35
Premarket Price	$0.34
Premarket Volume	7,914
Price vs 200-day SMA	-65.43%
RSI	53.88
RSI Monthly	37.3
RSI Weekly	39.69
Sharpe ratio	0.04x
Sortino ratio	0.11
Total Return	-408.93%
Tr YTD	-44.46
Tr1m	11.38%
Tr1w	29.33%
Tr3m	7.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-17.6M
Operating margin	-3,858.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11,693,528%
Float Percent	68.92%
Net Borrowing	468,500
Shares Insiders	16.34%
Shares Institutions	5.9%
Shares Out	16,967,420
Shares Qo Q	23.12%
Shares Yo Y	408.93%
Short Float	7.92%
Short Ratio	0.06
Short Shares	5.46

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.7M
Average Volume	850,639.25x
Bv Per Share	0.96
Ch1m	11.38
Ch1w	29.33
Ch1y	-76.78
Ch3m	7.59
Ch3y	-97.81
Ch6m	-81.4
Change	20.85%
Change From Open	18.14
Close	0.34
Days Gap	2.29
Depreciation Amortization	1,724,203
Dollar Volume	1,823,124.1
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-17.6M
EBITDA	$-15.9M
EPS	$-2.17
F Score	2
FCF	$-5.9M
FCF EV Yield	-100.95x
FCF Per Share	$-0.34
Financing CF	7,270,855
Fiscal Year End	December
Founded	2,021
Ipr	-89.73
Iprfo	-99.35
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-01
Last Report Date	2025-12-31
Last Split Date	2024-10-16
Last Split Type	Reverse
Last10k Filing Date	2026-04-01
Ma150	0.93
Ma150ch	-55.66%
Ma20	0.39
Ma20ch	4.61%
Net CF	1,427,685
Next Earnings Date	2026-05-22
Open	0.35
Optionable	No
Position In Range	66.95
Post Close	0.41
Postmarket Change Percent	0.05
Postmarket Price	$0.41
Ppne	309,655
Pre Close	0.34
Price Date	2026-05-08
Ptbv Ratio	7.2
Relative Volume	5.21x
Revenue	456,021x
SBC By Revenue	2,606.23x
Share Based Comp	11,884,972
Tr6m	-81.4%
Us State	Texas
Volume	4,435,825
Z Score	5.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does MGRX pay a dividend?

Capital-return profile for this ticker.

Performance

MGRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns MGRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.9%

Float: +68.9% of shares outstanding

Insider ownership

+16.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

MGRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.9

Neutral momentum band

Price vs 200-day MA

-65.4%

50/200-day relationship not available

Beta (5Y)

2.11

More volatile than the market

Sharpe ratio

0.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About MGRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current MGRX stock rating?

Mangoceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full MGRX analysis?

The full report lives at /stocks/MGRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for MGRX?

The latest report frames MGRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the MGRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.